Stock Report

Morepen Laboratories Ltd reports consolidated PAT of Rs. 15.81 crores in Q2FY23

Posted On : 2022-11-11 14:01:23( TIMEZONE : IST )

Morepen Laboratories Limited has reported Consolidated financial results for the period ended September 30, 2022.

Financial Results (Q2 FY2023) - QoQ Comparison

The company has reported total income of Rs. 403.8524 crores during the period ended September 30, 2022 as compared to Rs. 303.3149 crores during the period ended June 30, 2022.

The company has posted net profit / (loss) of Rs. 15.8109 crores for the period ended September 30, 2022 as against net profit / (loss) of Rs. 5.6299 crores for the period ended June 30, 2022.

The company has reported EPS of Rs. 0.33 for the period ended September 30, 2022 as compared to Rs. 0.11 for the period ended June 30, 2022.

Financials	Q2 FY2023	Q1 FY2023	% Change
Total Income	₹ 403.8524 crs	₹303.3149 crs	33.15%
Net Profit	₹15.8109 crs	₹5.6299 crs	180.84%
EPS	₹0.33	₹0.11	200.00%

Financial Results (Q2 FY2023) - YoY Comparison

The company has reported total income of Rs. 403.8524 crores during the period ended September 30, 2022 as compared to Rs.398.1672 crores during the period ended September 30, 2021.

The company has posted net profit / (loss) of Rs.15.8109 crores for the period ended September 30, 2022 as against net profit / (loss) of Rs.37.3638 crores for the period ended September 30, 2021.

The company has reported EPS of Rs.0.33 for the period ended September 30, 2022 as compared to Rs.0.72 for the period ended September 30, 2021.

Financials	Q2 FY2023	Q2 FY2022	% Change
Total Income	₹ 403.8524 crs	₹398.1672 crs	1.43%
Net Profit	₹15.8109 crs	₹37.3638 crs	-57.68%
EPS	₹0.33	₹0.72	-54.17%

Financial Results (Half Year Ended FY2023) - YoY Comparison

The company has reported total income of Rs.707.1673 crores during the 6 Months period ended September 30, 2022 as compared to Rs.786.4805 crores during the 6 Months period ended September 30, 2021.

The company has posted net profit / (loss) of Rs.21.4413 crores for the 6 Months period ended September 30, 2022 as against net profit / (loss) of Rs.67.8378 crores for the 6 Months period ended September 30, 2021.

The company has reported EPS of Rs.0.43 for the 6 Months period ended September 30, 2022 as compared to Rs.1.31 for the 6 Months period ended September 30, 2021.

Financials	Half Year Ended FY2023	Half Year Ended FY2022	% Change
Total Income	₹707.1673 crs	₹786.4805 crs	-10.08%
Net Profit	₹21.4413 crs	₹67.8378 crs	-68.39%
EPS	₹0.43	₹1.31	-67.18%

Shares of Morepen Laboratories Limited was last trading in BSE at Rs. 28.45 as compared to the previous close of Rs. 28.45. The total number of shares traded during the day was 297137 in over 1769 trades.

The stock hit an intraday high of Rs. 28.85 and intraday low of 27.95. The net turnover during the day was Rs. 8446917.00.